Jill O'Donnell-Tormey
Fortune : 42 000 $ au 30/06/2026
Fortune : 42 000 $ au 30/06/2026
Jill O'Donnell-Tormey is currently Director at City University of New York, Richmond University Medical Center, and The Staten Island Foundation.
Since 2022, the role of Independent Director at Coherus Oncology, Inc. is also held.
Former positions include CEO & Director-Scientific Affairs at Cancer Research Institute, Director at CT Atlantic Ltd., Director at Charles River Laboratories Cell Solutions, Inc. from 2018 to 2020, and Research Associate at Weill Cornell Medical College.
Education includes undergraduate studies at Fairleigh Dickinson University and a doctorate from SUNY Upstate Medical University.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 05/06/2026 | 30 000 ( 0,02% ) | 42 000 $ | 30/06/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| COHERUS ONCOLOGY, INC. | Directeur/Membre du Conseil | 18/05/2022 |
Richmond University Medical Center
Richmond University Medical Center Hospital/Nursing ManagementHealth Services Provides medical services | Directeur/Membre du Conseil | - |
The Staten Island Foundation
The Staten Island Foundation Investment Trusts/Mutual FundsMiscellaneous Operates as a non-profit organization that offers financial support and leadership for the community | Directeur/Membre du Conseil | - |
City University of New York
City University of New York Other Consumer ServicesConsumer Services Functions as a College/University | Directeur/Membre du Conseil | - |
| Sociétés | Poste | Fin |
|---|---|---|
| HEMACARE CORPORATION | Directeur/Membre du Conseil | 01/01/2020 |
Weill Cornell Medical College
Weill Cornell Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Cancer Research Institute
Cancer Research Institute Medical/Nursing ServicesHealth Services Provides cancer immunotherapy services | Directeur Général | - |
CT Atlantic Ltd.
CT Atlantic Ltd. Miscellaneous Commercial ServicesCommercial Services Provides research and development of human-derived antibodies for the treatment of cancer | Directeur/Membre du Conseil | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 10 |
|---|---|
Charles River Laboratories Cell Solutions, Inc.
Charles River Laboratories Cell Solutions, Inc. Chemicals: Major DiversifiedProcess Industries Engages in the provision of bioresearch products and services for customer's research and cell therapy protocols | Process Industries |
Cancer Research Institute
Cancer Research Institute Medical/Nursing ServicesHealth Services Provides cancer immunotherapy services | Health Services |
City University of New York
City University of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SUNY Upstate Medical University
SUNY Upstate Medical University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fairleigh Dickinson University
Fairleigh Dickinson University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Weill Cornell Medical College
Weill Cornell Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Richmond University Medical Center
Richmond University Medical Center Hospital/Nursing ManagementHealth Services Provides medical services | Health Services |
CT Atlantic Ltd.
CT Atlantic Ltd. Miscellaneous Commercial ServicesCommercial Services Provides research and development of human-derived antibodies for the treatment of cancer | Commercial Services |
The Staten Island Foundation
The Staten Island Foundation Investment Trusts/Mutual FundsMiscellaneous Operates as a non-profit organization that offers financial support and leadership for the community | Miscellaneous |
Coherus BioSciences, Inc.
Coherus BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a commercial-stage biopharmaceutical company that engages in research, development and commercialization of immunotherapies to treat cancer | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national